Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$17,500.00

Determining the role of the circadian clock mechanism in CD4+ T lymphocytes for inflammatory responses and healing post-myocardial infarction

FY 2013-14

Summary
Cardiovascular disease (CVD) is the leading cause of death worldwide. Along with almost all tissues and organs, the cardiovascular system is under circadian control. This circadian rhythmicity is evident in the incidence of myocardial infarction (MI) where peak time of onset occurs in the early morning hours. Following the onset of MI, a coordinated innate and adaptive immune response is initiated which facilitates infarct healing. The key immune cells involved in these processes are also under circadian control, with characterized rhythms in circulating cell numbers and antigen-recognition responses over the course of a day. Disruption of this intricate circadian control leads to adverse physiological conditions in both the cardiovascular and immune systems. For example, chronic circadian disruptions from shift work have been shown to promote exaggerated adaptive immune cell responses as well as increase the risk of adverse cardiovascular events. The key effector cells of the adaptive immune system, known as T lymphocytes, have been implicated in healing and survival post-MI and thus are a key target for investigation. Determining whether light-dark (LD) or genetic models of circadian clock disruption affect the temporal response of T cells post-MI will highlight the importance of circadian rhythms in regulating infarct healing. Pharmacological intervention targeting the clock mechanism could lead to novel therapies in CVD patients with circadian rhythm disruption. I hypothesize that T lymphocytes play a critical role in promoting healing post-MI and disruption of the circadian clock within these cells negatively affects outcome. Crossover between factors involved in the clock mechanism and in T cell responses can lead to novel targets for therapeutic intervention post-MI. I will first use a LD model of circadian rhythm disruption by housing mice on a normal 12hr light: 12 hr dark and a disrupted 10:10 LD schedule post-MI. Hearts will be collected over the first 14 days post-MI and immunohistochemistry will be used to quantify the changes T cell infiltration into the infarcted area. Next I will use genetic models of disruption, with Clock delta 19 mutant male mice who have a whole body defect in the clock mechanism and in a novel CD4+ T cell-specific knockout of the core circadian gene, Bmal1. Flow cytometry will be performed to quantify the temporal response of various T cell lineages. Finally, the circadian protein Rev-erb alpha has been implicated in T cell responses, through modulation of cytokine levels and in the differentiation of proinflammatory T cells. Chronic circadian disruptions, such as shift work have been shown to exaggerate these T cell responses, thus stimulating Rev-erb alpha in these individuals may have therapeutic benefit. Following experimental MI, I will treat mice with Rev-erb alpha agonist, SR9009, and characterize the effects of treatment. All animals will be followed for 8-12 weeks post-MI to determine outcome. Cardiac structure and function will be monitored using echocardiography, cardiac contractility will be assessed using in vivo hemodynamics and heart/scar morphology characterized using Masson’s trichrome staining. This study will highlight the role of the circadian clock in the recruitment of immune cells post-MI. It will determine the pathological consequences of disrupting circadian rhythms and the importance of maintaining normal rhythms in the weeks following MI. These studies will lead to new approaches to benefit patients clinically.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
311827
Name
Reitz Cristine J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the role of the circadian clock mechanism in CD4+ T lymphocytes for inflammatory responses and healing post-myocardial infarction
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular; Cd4+ T Lymphocytes; Circadian Disruption; Circadian Rhythms; Conditional Knockout; Immune; Myocardial Infarction; Pharmacological Therapy
Abstract
Cardiovascular disease (CVD) is the leading cause of death worldwide. Along with almost all tissues and organs, the cardiovascular system is under circadian control. This circadian rhythmicity is evident in the incidence of myocardial infarction (MI) where peak time of onset occurs in the early morning hours. Following the onset of MI, a coordinated innate and adaptive immune response is initiated which facilitates infarct healing. The key immune cells involved in these processes are also under circadian control, with characterized rhythms in circulating cell numbers and antigen-recognition responses over the course of a day. Disruption of this intricate circadian control leads to adverse physiological conditions in both the cardiovascular and immune systems. For example, chronic circadian disruptions from shift work have been shown to promote exaggerated adaptive immune cell responses as well as increase the risk of adverse cardiovascular events. The key effector cells of the adaptive immune system, known as T lymphocytes, have been implicated in healing and survival post-MI and thus are a key target for investigation. Determining whether light-dark (LD) or genetic models of circadian clock disruption affect the temporal response of T cells post-MI will highlight the importance of circadian rhythms in regulating infarct healing. Pharmacological intervention targeting the clock mechanism could lead to novel therapies in CVD patients with circadian rhythm disruption. I hypothesize that T lymphocytes play a critical role in promoting healing post-MI and disruption of the circadian clock within these cells negatively affects outcome. Crossover between factors involved in the clock mechanism and in T cell responses can lead to novel targets for therapeutic intervention post-MI. I will first use a LD model of circadian rhythm disruption by housing mice on a normal 12hr light: 12 hr dark and a disrupted 10:10 LD schedule post-MI. Hearts will be collected over the first 14 days post-MI and immunohistochemistry will be used to quantify the changes T cell infiltration into the infarcted area. Next I will use genetic models of disruption, with Clock delta 19 mutant male mice who have a whole body defect in the clock mechanism and in a novel CD4+ T cell-specific knockout of the core circadian gene, Bmal1. Flow cytometry will be performed to quantify the temporal response of various T cell lineages. Finally, the circadian protein Rev-erb alpha has been implicated in T cell responses, through modulation of cytokine levels and in the differentiation of proinflammatory T cells. Chronic circadian disruptions, such as shift work have been shown to exaggerate these T cell responses, thus stimulating Rev-erb alpha in these individuals may have therapeutic benefit. Following experimental MI, I will treat mice with Rev-erb alpha agonist, SR9009, and characterize the effects of treatment. All animals will be followed for 8-12 weeks post-MI to determine outcome. Cardiac structure and function will be monitored using echocardiography, cardiac contractility will be assessed using in vivo hemodynamics and heart/scar morphology characterized using Masson’s trichrome staining. This study will highlight the role of the circadian clock in the recruitment of immune cells post-MI. It will determine the pathological consequences of disrupting circadian rhythms and the importance of maintaining normal rhythms in the weeks following MI. These studies will lead to new approaches to benefit patients clinically.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Reitz, Cristine J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~